Skip to content

Evaluation of Erythropoietin's effect in patients consciousness

Evaluation of Erythropoietin's effect in patients consciousness with severe Traumatic Brain Injury

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190429043416N1
Enrollment
18
Registered
2019-06-22
Start date
2019-02-14
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury. Other specified intracranial injury with loss of consciousness of unspecified duration

Interventions

Intervention 1: Intervention group: After 24 hours of brian injury 40000 unit of Erythropoietin Ampule via intravenous pathway is injected and patients receive 8000 unit of Erythropoietin intravenousl

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Range of Age between 15-65 years Traumatic Brain Injury(Epidural, Subdural, Intracranial, Intraventricular, Subarachnoid Hemorrhage, Diffuse Axonal Injury) Level of consciousness equal and less than 9 Hemoglobin less than 18 Mean Arterial Pressure less than 130 Onset of Brain Injury less than 24 hours Lack of History of Venous Thrombosis

Exclusion criteria

Exclusion criteria: Oragn Dysfunction(Uremic and Hepatic Encephalopathy) History of Malignancy

Design outcomes

Primary

MeasureTime frame
Level of Consciousness. Timepoint: Evaluation of level of consciousness in initial of the study(before intervention) and daily until two weeks after Erythropoietin injection. Method of measurement: Glascow Coma Score, Four Score.

Secondary

MeasureTime frame
Time course for complete wakefullness after first Erythropoietin or Placebo injection. Timepoint: Daily until two weeks after Erythropoietin or Placebo injection. Method of measurement: Nursing Questionary.;Time course after Brain Injury until first Erythropoietin or Placebo injection. Timepoint: Onset of the study (before injection). Method of measurement: Nursing Questionary.;Time course for increasing in Glascow Coma Score and Four Score after first Erythropoietin or Placebo injection. Timepoint: Daily until two weeks after Erythropoietin or Placebo injection. Method of measurement: Nursing Questionary.;Incidense of Deep Vein Thrombosis. Timepoint: Daily from first Erythropoietin injection until last injection. Method of measurement: Physical Exam, Doppler Ultra Sonography of lower Extremity.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtabak Najafi

Tehran University of Medical Sciences

nadjafia@tums.ac.ir+98 21 6634 8500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026